Brought to you by 
Series B for Atlas Genetics brings in £2.1mm; closes round at £16.9mm
03 Feb 2015
Executive Summary
Molecular diagnostics company Atlas Genetics has raised £2.1mm ($4.1mm) in a second venture round to returning shareholders South West Ventures Fund, GEIF Ventures, and individual investors from the South West Angel and Investor Network. First-time backers Finance South West Growth Fund and Braveheart Ventures also participated.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B for Atlas Genetics brings in £2.1mm; closes round at £16.9mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice